[Federal Register Volume 59, Number 157 (Tuesday, August 16, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-19940]


[[Page Unknown]]

[Federal Register: August 16, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

 

Meeting; Forum on Cooperative Research and Development Agreements

    Notice is hereby given that a second Forum on Cooperative Research 
and Development Agreements (CRADAs), convened as an ad hoc group of 
consumer consultants to the Advisory Committee to the Director, NIH, 
will meet in public session on September 8, 1994, from 8:30 am to 5:30 
pm, at the Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, Maryland, 
20814. This Forum is convened in follow-up to a previous Forum on this 
topic July 21, 1994.
    The purpose of the second Forum is to elicit consumer and other 
public interest perspectives which will be used in NIH's development of 
policy on the ``reasonable pricing'' clause, which is currently 
required in its Cooperative Research and Development Agreements 
(CRADAs) under the Federal Technology Transfer Act of 1986 and 
exclusive commercialization licenses. The Forum Panel members will 
discuss how best to ensure that the public investment in products 
developed through licensing NIH technologies is adequately reflected. 
Discussion will include an analysis of the clause and the Panel will 
advise on whether the clause has been useful to ensure that the public 
investment in collaborative research is adequately considered in the 
subsequent commercial development of technology arising under such 
research.
    At the conclusion of the Forum, the Panel will develop and transmit 
its report to the Advisory Committee to the Director, NIH, for review.
    Concerned organizations and individuals are invited to present 
their views at the Forum or submit written views of any length to the 
Panel. Please submit requests for a 5 minute presentation time, or 
written views to: Ms. Elyssa Tran, Office of Science Policy and 
Technology Transfer, National Institutes of Health, Building 1, Room 
218, 9000 Rockville Pike, Rockville, MD 20892, (301) 402-0280 (fax).
    Written views submitted by September 1 will be distributed to the 
Panel. Comments and questions related to the proposed Forum may also be 
addressed to Ms. Tran at (301) 496-1454.

    Dated: August 8, 1994.
Ruth Kirschstein, M.D.,
Deputy Director, NIH.
[FR Doc. 94-19940 Filed 8-15-94; 8:45 am]
BILLING CODE 4140-01-P